|
FR2611501B1
(fr)
*
|
1987-03-04 |
1991-12-06 |
Corbiere Jerome |
Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
|
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
|
JP3382159B2
(ja)
*
|
1998-08-05 |
2003-03-04 |
株式会社東芝 |
情報記録媒体とその再生方法及び記録方法
|
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
|
FR2796551B1
(fr)
*
|
1999-07-23 |
2003-07-25 |
Lipha |
Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
|
|
FR2796940B1
(fr)
*
|
1999-07-26 |
2005-04-08 |
Lipha |
Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
|
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
WO2002036100A1
(en)
|
2000-11-03 |
2002-05-10 |
Andrx Corporation |
Controlled release metformin compositions
|
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
AU2003241537A1
(en)
*
|
2002-05-23 |
2003-12-12 |
Andrx Corporation |
Biguanide formulations
|
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
|
KR101363679B1
(ko)
|
2002-09-20 |
2014-02-14 |
안드렉스 랩스 엘엘씨 |
약제학적 정제
|
|
CA2543181A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
|
|
WO2008093984A1
(en)
*
|
2007-01-29 |
2008-08-07 |
Hanall Pharmaceutical Company. Ltd |
N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
|
|
CN101855204B
(zh)
*
|
2007-09-21 |
2013-09-11 |
韩兀生物制药株式会社 |
N,n-二甲基亚氨二羰酸二酰胺二羧酸盐、其制备方法及其药物组合物
|
|
EP2303838B1
(en)
|
2008-06-26 |
2013-12-04 |
Laboratorios Silanes, S.A. de C.V. |
A new metformin glycinate salt for blood glucose control
|
|
WO2010146604A2
(en)
|
2009-06-18 |
2010-12-23 |
Exemed Pharmaceuticals |
Processes for preparing metformin hydrochloride
|
|
WO2011049400A2
(ko)
*
|
2009-10-23 |
2011-04-28 |
한올바이오파마주식회사 |
N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
|
|
CN101691344B
(zh)
*
|
2009-10-26 |
2012-10-17 |
漆又毛 |
一种二甲双胍酸式复盐化合物及制备方法
|
|
KR101860120B1
(ko)
|
2010-05-26 |
2018-05-23 |
브이티브이 테라퓨틱스 엘엘씨 |
글루코키나아제 활성화제와 병용되는 메트포르민의 용도, 및 메트포르민과 글루코키나아제 활성화제를 포함하는 조성물
|
|
US8440723B2
(en)
*
|
2011-05-11 |
2013-05-14 |
Banavara L. Mylari |
Metformin salts of salicylic acid and its congeners
|
|
ES2878001T3
(es)
|
2012-05-17 |
2021-11-18 |
Vtv Therapeutics Llc |
Composiciones del activador de la glucocinasa para el tratamiento de la diabetes
|
|
MX2019003725A
(es)
|
2016-09-30 |
2019-08-12 |
Laboratorios Silanes S A De C V |
Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma.
|
|
WO2018060962A2
(en)
|
2016-09-30 |
2018-04-05 |
Laboratorios Silanes S.A. De C.V. |
Metformin amino acid compounds and methods of using the same
|
|
CN107118130A
(zh)
*
|
2017-05-11 |
2017-09-01 |
杜剑平 |
一类治疗肿瘤的药物化合物及其应用
|
|
EP4487909A3
(en)
|
2018-06-12 |
2025-03-19 |
vTv Therapeutics LLC |
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
|
|
US12391658B2
(en)
|
2020-02-18 |
2025-08-19 |
Vtv Therapeutics Llc |
Sulfoxide and sulfone glucokinase activators and methods of use thereof
|
|
CN115073330A
(zh)
*
|
2021-03-15 |
2022-09-20 |
中国医学科学院药物研究所 |
二甲双胍肉桂酸盐及制备方法和其组合物与用途
|